CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
Research and development	$ 19,606	$ 7,829	$ 46,669	$ 22,825
General and administrative	4,642	3,105	14,131	5,803
Total operating expenses	24,248	10,934	60,800	28,628
Loss from operations	(24,248)	(10,934)	(60,800)	(28,628)
Other income (expense), net
Interest income	3,492	380	8,599	516
Other expense	(13)	(0)	(13)	(0)
Total other income (expense), net	3,479	380	8,586	516
Net loss	(20,769)	(10,554)	(52,214)	(28,112)
Other comprehensive income (loss):
Net unrealized losses on marketable securities	(36)	(0)	(147)	(0)
Comprehensive loss	$ (20,805)	$ (10,554)	$ (52,361)	$ (28,112)
Net loss per share, basic	$ (0.51)	$ (3.27)	$ (1.55)	$ (9.15)
Net loss per share, diluted	$ (0.51)	$ (3.27)	$ (1.55)	$ (9.15)
Weighted-average shares outstanding, basic	41,030,874	3,228,692	33,665,067	3,071,104
Weighted-average shares outstanding, diluted	41,030,874	3,228,692	33,665,067	3,071,104